ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66 | -99.4% | 3,945 | +352.9% | 0.00% | – |
| Q3 2022 | $12,000 | -97.7% | 871 | -95.6% | 0.00% | – |
| Q1 2022 | $531,000 | +126.0% | 19,710 | +209.4% | 0.00% | – |
| Q4 2021 | $235,000 | +739.3% | 6,371 | +694.4% | 0.00% | – |
| Q3 2021 | $28,000 | -60.0% | 802 | -61.3% | 0.00% | – |
| Q2 2021 | $70,000 | -82.2% | 2,075 | -78.2% | 0.00% | -100.0% |
| Q1 2021 | $393,000 | +934.2% | 9,535 | +971.3% | 0.00% | – |
| Q4 2020 | $38,000 | +1166.7% | 890 | +959.5% | 0.00% | – |
| Q2 2020 | $3,000 | -93.0% | 84 | -97.4% | 0.00% | – |
| Q1 2020 | $43,000 | -70.1% | 3,224 | -75.7% | 0.00% | – |
| Q4 2019 | $144,000 | +13.4% | 13,292 | +7.0% | 0.00% | – |
| Q3 2019 | $127,000 | +477.3% | 12,420 | +413.0% | 0.00% | – |
| Q2 2019 | $22,000 | – | 2,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |